ALOX5AP and metabolic dysfunction-associated steatotic liver disease: These results confirm the regulatory role of ALOX5AP+ macrophages in Th17 cell polarization and establish ALOX5AP as a critical target for treating NAFLD with concurrent kidney fibrosis.